Skip to content
10-Q

Quarterly Report

XTANT MEDICAL HOLDINGS, INC. XTNT

0001493152-25-021512

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 140M sh
Shares Diluted Q3 2025 · Sep 30, 2025 150.38M sh
Shares Diluted Q3 2025 · Sep 30, 2025 149.91M sh
Shares Diluted Q3 2025 · Sep 30, 2024 135.1M sh
Shares Diluted Q3 2025 · Sep 30, 2024 131.88M sh
Capex Q3 2025 · Sep 30, 2025 $1.99M
Capex Q3 2025 · Sep 30, 2024 $3.44M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $7.17M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$12.56M
Long Term Debt Q3 2025 · Sep 30, 2025 $17.4M
Long Term Debt Q3 2025 · Dec 31, 2024 $22.04M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $10.4M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $6.2M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $6.6M
Stockholders Equity Q3 2025 · Sep 30, 2025 $50.38M
Stockholders Equity Q3 2025 · Jun 30, 2025 $48.5M
Stockholders Equity Q3 2025 · Mar 31, 2025 $43.88M
Stockholders Equity Q3 2025 · Dec 31, 2024 $42.96M
Stockholders Equity Q3 2025 · Sep 30, 2024 $45.73M
Stockholders Equity Q3 2025 · Jun 30, 2024 $45.01M
Stockholders Equity Q3 2025 · Mar 31, 2024 $47.68M
Stockholders Equity Q3 2025 · Dec 31, 2023 $51.35M
Current Liabilities Q3 2025 · Sep 30, 2025 $35.5M
Current Liabilities Q3 2025 · Dec 31, 2024 $28.58M
Total Liabilities Q3 2025 · Sep 30, 2025 $55.94M
Total Liabilities Q3 2025 · Dec 31, 2024 $50.87M
Current Assets Q3 2025 · Sep 30, 2025 $78.33M
Current Assets Q3 2025 · Dec 31, 2024 $67.12M
Total Assets Q3 2025 · Sep 30, 2025 $106.32M
Total Assets Q3 2025 · Dec 31, 2024 $93.84M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.01
Eps Diluted Q3 2025 · Sep 30, 2025 $0.03
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.10
Eps Basic Q3 2025 · Sep 30, 2025 $0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.10
Sga Expense Q3 2025 · Sep 30, 2025 $7.07M
Sga Expense Q3 2025 · Sep 30, 2025 $22.08M
Sga Expense Q3 2025 · Sep 30, 2024 $7.49M
Sga Expense Q3 2025 · Sep 30, 2024 $22.99M
Rd Expense Q3 2025 · Sep 30, 2025 $634K
Rd Expense Q3 2025 · Sep 30, 2025 $1.64M
Rd Expense Q3 2025 · Sep 30, 2024 $701K
Rd Expense Q3 2025 · Sep 30, 2024 $1.86M
Net Income Q3 2025 · Sep 30, 2025 $1.31M
Net Income Q3 2025 · Sep 30, 2025 $4.92M
Net Income Q3 2025 · Jun 30, 2025 $3.55M
Net Income Q3 2025 · Mar 31, 2025 $58K
Net Income Q3 2025 · Sep 30, 2024 −$5.02M
Net Income Q3 2025 · Sep 30, 2024 −$13.28M
Net Income Q3 2025 · Jun 30, 2024 −$3.86M
Net Income Q3 2025 · Mar 31, 2024 −$4.4M
Operating Income Q3 2025 · Sep 30, 2025 $2.54M
Operating Income Q3 2025 · Sep 30, 2025 $8.23M
Operating Income Q3 2025 · Sep 30, 2024 −$3.78M
Operating Income Q3 2025 · Sep 30, 2024 −$10.19M
Gross Profit Q3 2025 · Sep 30, 2025 $21.99M
Gross Profit Q3 2025 · Sep 30, 2025 $66.52M
Gross Profit Q3 2025 · Sep 30, 2024 $16.31M
Gross Profit Q3 2025 · Sep 30, 2024 $52.19M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $11.26M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $35.05M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $11.63M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $33.56M
Revenue Q3 2025 · Sep 30, 2025 $33.26M
Revenue Q3 2025 · Sep 30, 2025 $101.57M
Revenue Q3 2025 · Sep 30, 2024 $27.94M
Revenue Q3 2025 · Sep 30, 2024 $85.75M